Rad AI announces $4M funding round led by Google’s Gradient Ventures

Rad AI, a Berkeley, California-based healthcare startup focused on bringing AI to radiology, is launching with a $4 million funding round. The round was led by Gradient Ventures, Google’s venture fund dedicated to AI-related investments.

The funds are expected to go toward expanding Rad AI’s engineering team and escalating the rollout of its initial offerings. The company’s first solution was designed to automatically generate a customized “impression” section for radiology reports using machine learning.

“Radiology is facing severe pressures that range from falling reimbursements to market consolidation,” Jeffrey Chang, MD, Rad AI co-founder, said in a prepared statement. “There is also a radiologist shortage that is exacerbated by rising imaging volumes nationwide. We help radiology groups significantly increase productivity, while reducing radiologist burnout and improving report accuracy.”

“The team at Rad AI is uniquely suited to apply innovative technology to this field, with strong radiology and AI experts and firsthand knowledge of this market,” Zachary Bratun-Glennon, partner at Gradient Ventures, said in the same statement. “It's exciting to see the quantitative benefits and positive feedback from their radiology customers, and we're looking forward to the impact of their future products.”

Other investors participating in this round included UP2398, Precursor Ventures, GMO Venture Partners, Array Ventures, Hike Ventures and Fifty Years VC.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.